MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects focused on managing healthcare, understanding diagnosis and disease progression, enhancing care, discovering novel treatments and therapies and moving research towards the development of cures. 

This year, the funded studies focus on Spinal muscular atrophy, Duchenne muscular dystrophy, myotonic dystrophy, dysferlinopathies, limb-girdle muscular dystrophies, immune-mediated myopathies, autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and cross-cutting research with findings that will inform a wide range of neuromuscular disorders. Additionally, thanks to the generosity of their supporters, MDC was able to invest $63,630 towards an innovative natural history study led by NMD4C investigator Dr. Hernan Gonorazky on Charcot-Marie-Tooth disease, bringing the organization’s investment in research projects close to $1 million. 

Congratulations to NMD4C investigators Dr. Rashmi Kothary and Dr. Gerald Pfeffer, whose respective projects “Maternal transfer of AAV vectors: a minimally invasive approach to deliver SMN-gene therapy for SMA” and “Single nucleus RNAseq biomarkers in adult-onset muscle diseases” are among those that received MDC funding. 

Read the press release from MDC for the full list of funded projects!

 

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Read next...

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.

NMD4C Launches Pre‑Clinical Expertise & Resource Database of Canadian Neuromuscular Labs

NMD4C Launches Pre‑Clinical Expertise & Resource Database of Canadian Neuromuscular Labs

NMD4C announces the launch of its Pre-Clinical Expertise & Resources Database, a resource designed to showcase neuromuscular research expertise, specialized techniques, unique resources, and training opportunities across Canada.